These features may account for the original SCLC diagnosis, however the morphology and IHC profile of the SMARCA4-deficient SCLC-Y xenografts were unanimously considered by a panel of pathologists to be consistent with thoracic SMARCA4-UT or SMARCA4-deficient carcinoma as opposed to SCLC. Here, SMARCA4 is linked to carcinoma.